RNS Number : 8322G
Mears Group PLC
04 October 2024
 

4 October 2024

Mears Group PLC

Transaction in Own Shares

Mears Group PLC ('Mears' or the 'Group') announces that, in accordance with the terms of its share buyback programme announced on 22 August 2024 (the 'Buyback Programme'), the Group has purchased the following number of ordinary shares of 1 penny each (the 'Ordinary Shares') through Panmure Liberum Limited.

Date of purchase

3 October 2024

Number of Ordinary Shares purchased: 

100,000

Highest price paid per share (GBp):

378.50

Lowest price paid per share (GBp):

377.25

Volume weighted average price paid (GBp):

377.2718

 

The purchased Ordinary Shares will be cancelled. Since the announcement of the Buyback Programme on 22 August 2024, Mears has purchased 2,840,298 Ordinary Shares in aggregate for cancellation. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Panmure Liberum Limited on behalf of Mears as part of the share buyback programme.

For further information, contact:

 

 

 

Mears Group PLC

Tel: +44(0)1452 634 600

Andrew Smith

 

Lucas Critchley

 

 

 

Deutsche Numis

Tel: +44(0)207 260 1000

Julian Cater

 

Kevin Cruickshank

 

 

 

Panmure Liberum

Tel: +44(0)20 3100 2000

Tom Scrivens

 

James Sinclair-Ford

 

 

Individual Transactions

 

Number of ordinary shares purchased

Transaction price
(GBp share)

Time of transaction (UK Time)

Transaction reference number

Trading venue

21

378.5

09:25:44

00019965663TRLO0

AIMX

192

378.5

09:25:44

00019965662TRLO0

AIMX

177

378.5

09:25:44

00019965661TRLO0

AIMX

1505

378

09:27:38

00019965742TRLO0

AIMX

758

378

09:28:38

00019965799TRLO0

AIMX

97347

377.25

09:36:39

00019966038TRLO0

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUPGUUUUPCUBW